BAYWOOD INTERNATIONAL INC
10QSB, 2000-05-15
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: LEHMAN BROTHERS HOLDINGS INC, 13F-HR/A, 2000-05-15
Next: MUNDER CAPITAL MANAGEMENT INC /MI /, 13F-HR, 2000-05-15



                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                   FORM 10-QSB


   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
                                  ACT OF 1934


 FOR THE QUARTER ENDED                                    COMMISSION FILE NUMBER
 ---------------------                                    ----------------------
    March 31, 2000                                                0-22024


                           BAYWOOD INTERNATIONAL, INC.
        (Exact name of small business issuer as specified in its charter)


            Nevada                                              77-0125664
(state or other jurisdiction of                              (I.R.S. Employer
incorporation or organization)                            Identification Number)


                         14950 North 83rd Place, Suite 1
                            Scottsdale, Arizona 85260
                    (Address of principal office) (Zip code)

       Registrant's telephone number, including area code: (602) 951-3956

           Securities registered pursuant to Section 12(b) of the Act:
                                      None

           Securities registered pursuant to Section 12(g) of the Act:
                          $.001 par value common stock

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the  Securities  and  Exchange Act of 1934
during the preceding 12 months (or for such shorter  periods that the registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past 90 days.

                             YES [X]   NO [ ]

As of March 31, 2000,  there were  26,966,259  shares of Baywood  International,
Inc. common stock, $.001 par value outstanding.
<PAGE>
                           BAYWOOD INTERNATIONAL, INC.

                                      INDEX

                                                                            Page
                                                                            ----

PART I - FINANCIAL INFORMATION

         Item 1 - Financial Statements

         Balance Sheet as of March 31, 2000                                    3

         Statements of Operations for the three months ended                   4
           March 31, 2000 and 1999

         Statements of Cash Flows for the three months ended                   5
           March 31, 2000 and 1999

         Statement of Information Furnished                                    6

         Item 2 - Management's Discussion and Analysis or
           Plan of Operation                                              7 - 11


PART II - OTHER INFORMATION

         Item 1 - Legal Proceedings                                           12

         Item 2 - Changes in Securities                                       12

         Item 3 - Defaults Upon Senior Securities                             12

         Item 4 - Submission of Matters to a Vote of Security Holders         12

         Item 5 - Other Information                                           12

         Item 6 - Exhibits and Reports on Form 8-K                            12

         SIGNATURES                                                           14

                                      -2-
<PAGE>
                          BAYWOOD INTERNATIONAL, INC.

                                  BALANCE SHEET
                                 March 31, 2000

                                     ASSETS

CURRENT ASSETS
      Cash and equivalents                                          $    71,462
      Accounts receivable                                               212,884
      Inventories                                                       128,584
      Prepaid expenses and other current assets                          27,606
                                                                    -----------
            Total current assets                                        440,536
                                                                    -----------

PROPERTY & EQUIPMENT
      Furniture, fixtures, computers and equipment                       55,479
                                                                    -----------

OTHER ASSETS
      Investment in BII Acquisition Company                              75,000
                                                                    -----------
            Total other assets                                           75,000
                                                                    -----------
                  Total assets                                      $   571,015
                                                                    ===========

                      LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES
      Accounts payable                                              $   315,430
      Interest payable                                                  106,293
      Accrued liabilities                                               182,795
                                                                    -----------
            Total current liabilities                                   604,518
                                                                    -----------

NOTES PAYABLE                                                         1,171,888
                                                                    -----------

STOCKHOLDERS' DEFICIT
      Preferred Stock, $1 par value,
         10,000,000 shares authorized,
         35,000 Class A shares issued and outstanding                    35,000
         20,000 Class D shares issued and outstanding                    20,000
      Common stock, $.001 par value, 50,000,000
         shares authorized, 26,966,259 shares
         issued and outstanding                                          26,966
      Additional paid-in capital                                      6,707,387
      Accumulated deficit                                            (7,994,744)
                                                                    -----------
            Total stockholders' deficit                              (1,205,391)
                                                                    -----------
                  Total liabilities and stockholders' deficit       $   571,015
                                                                    ===========

                                      -3-
<PAGE>
                          BAYWOOD INTERNATIONAL, INC.

                            STATEMENTS OF OPERATIONS

<TABLE>
<CAPTION>
                                                            Three Months Ended March 31,
                                                            ----------------------------
                                                                2000            1999
                                                            ------------    ------------
<S>                                                         <C>             <C>
NET SALES                                                   $    359,082    $     37,971

COST OF SALES                                                    126,658          22,190
                                                            ------------    ------------
      Gross profit                                               232,424          15,781
                                                            ------------    ------------

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES:
      Marketing expenses                                         309,251         123,507
      General and administrative expenses                        133,425          92,846
      Depreciation and amortization                                  994              --
                                                            ------------    ------------
            Total selling, general and administrative
              expenses                                           443,670         216,353
                                                            ------------    ------------
                  Operating loss                                (211,246)       (200,572)
                                                            ------------    ------------

OTHER INCOME (EXPENSE):
      Interest income                                                207              62
      Miscellaneous expense                                       (2,778)             --
      Miscellaneous income                                        15,183             337
      Interest expense                                           (37,508)         (7,498)
      Equity in net loss of investee                                  --          (6,512)
                                                            ------------    ------------
            Total other (expense)                                (24,896)        (13,611)
                                                            ------------    ------------

LOSS BEFORE INCOME TAXES                                        (236,142)       (214,183)

PROVISION FOR INCOME TAXES                                            --              --
                                                            ------------    ------------

NET LOSS                                                    $   (236,142)   $   (214,183)
                                                            ============    ============

NET LOSS PER COMMON SHARE                                   $      (0.01)   $      (0.01)
                                                            ============    ============

DILUTED NET LOSS PER COMMON SHARE                           $         --    $         --
                                                            ============    ============

WEIGHTED AVERAGE OF COMMON SHARES OUTSTANDING                 26,312,413      24,952,472
                                                            ============    ============
</TABLE>

**  not presented because the effect of such would be antidilutive

                                      -4-
<PAGE>
                          BAYWOOD INTERNATIONAL, INC.

                            STATEMENTS OF CASH FLOWS

<TABLE>
<CAPTION>
                                                                 Three Months Ended March 31,
                                                                 ----------------------------
                                                                     2000           1999
                                                                   ---------      ---------
<S>                                                                <C>            <C>
OPERATING ACTIVITIES:
  Net loss                                                         $(236,142)     $(214,183)
  Adjustments to reconcile net loss
    to cash used in operating activities:
      Depreciation and amortization                                      994             --
      Issuance of common stock for services performed                     --         75,000
      Equity in net loss of investee                                      --          6,912
    Changes in assets and liabilities:
      (Increase) in accounts receivable                              (65,477)       (13,502)
      Increase in interest payable                                    22,409          6,088
      (Increase) decrease in inventory                               (78,822)         4,369
      (Increase) in prepaid expenses                                  (5,089)        (7,001)
      (Decrease) in accounts payable and accrued liabilities          (3,591)       (55,983)
                                                                   ---------      ---------
         Net cash (used) by operating activities                    (365,718)      (198,300)
                                                                   ---------      ---------

INVESTING ACTIVITIES:
      Purchase of computers and fixtures                             (37,762)            --
                                                                   ---------      ---------
         Net cash (used) by investing activities                     (37,762)            --
                                                                   ---------      ---------

FINANCING ACTIVITIES:
      Issuance of common and preferred stock for cash                     --         10,000
      Fees paid in connection with offering of preferred stock            --        (10,022)
      Proceeds from exercise of stock options and warrants           222,200         13,000
      Proceeds from notes payable                                    240,000        233,300
      Principal payments on notes payable                             (2,500)       (73,989)
                                                                   ---------      ---------
         Net cash provided by financing activities                   459,700        172,289
                                                                   ---------      ---------

CASH AND EQUIVALENTS PROVIDED
  (USED) DURING PERIOD                                                56,220        (26,011)
CASH AND EQUIVALENTS, BEGINNING OF PERIOD                             15,242         40,869
                                                                   ---------      ---------
CASH AND EQUIVALENTS, END OF PERIOD                                $  71,462      $  14,858
                                                                   =========      =========

SUPPLEMENTAL DISCLOSURES AND CASH FLOW INFORMATION:
    Cash paid during the period for:
      Interest                                                     $   8,600      $   1,410
</TABLE>

                                      -5-
<PAGE>
                           BAYWOOD INTERNATIONAL, INC.

STATEMENT OF INFORMATION FURNISHED

         The accompanying  financial statements have been prepared in accordance
with Form  10-QSB  instructions  and in the  opinion of  management  contain all
adjustments  (consisting  of only normal and  recurring  accruals)  necessary to
present  fairly the  financial  position as of March 31, 2000 and the results of
operations for the three months ended March 31, 2000 and 1999 and the cash flows
for the three  months  ended March 31, 2000 and 1999.  These  results  have been
determined  on  the  basis  of  generally  accepted  accounting  principles  and
practices  applied  consistently  with  those  used  in the  preparation  of the
Company's 1999 Annual Report on Form 10-KSB.

         Certain  information  and  footnote  disclosures  normally  included in
financial  statements presented in accordance with generally accepted accounting
principles have been condensed or omitted. It is suggested that the accompanying
financial  statements be read in conjunction  with the financial  statements and
notes thereto  incorporated  by reference in the Company's 1999 Annual Report on
Form 10-KSB.

                                      -6-
<PAGE>
                          BAYWOOD INTERNATIONAL, INC.

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

GENERAL

         Baywood  International,  Inc. (the  "Company"),  develops,  markets and
distributes  natural-based consumer products.  Currently,  the Company's natural
consumer products consist of two dietary  supplement lines,  PURECHOICE(TM)  and
SOLUTIONS(TM).  Prior to 1998, the Company's  product lines consisted of dietary
supplements  and skin care products which were  distributed  into  international
markets such as the Pacific Rim and European  Countries.  During that time prior
to 1998,  the  Company's  product line had not been expanded in order to capture
the  domestic  market.  As  a  result,  the  Company  relied  on  the  continued
distribution  of one main  product to one major  customer in China.  In March of
1998, due to governmental  restrictions in China, this customer discontinued its
purchases which caused a dramatic decrease in the Company's sales for 1998.

         Throughout  1998  and  the  first  six  months  of  1999,  the  Company
completely  revamped  its  corporate  strategy  to  turn  itself  around  from a
primarily  internationally  focus with no proprietary  brand lines to a domestic
focus  with  identifiable  brands  across  retail  channels.  The result of this
turn-around strategy was a fundamentally  different company with a new corporate
image, product lines,  marketing campaign,  and distribution  channels.  At this
time, the Company is continually  exploring the  international  market,  but has
focused on  strengthening  the domestic  marketing  and sales of its new branded
product lines, PURECHOICE(TM) and SOLUTIONS(TM) in the United States.

         The Company's  principal  executive  offices are located at 14950 North
83rd Place, Suite 1, Scottsdale, Arizona 85260 and its telephone number is (480)
951-3956.

COMPANY OVERVIEW

         The  direction the Company takes in carrying out its objective is based
upon the following mission and will remain as the primary focus by the Company's
management:

     MAKE LIFE  BETTER(TM)  THROUGH THE DEVELOPMENT OF HIGH QUALITY NATURAL
     CONSUMER  PRODUCTS  THAT  PEOPLE  WANT AND NEED  WHILE  PROVIDING  THE
     HIGHEST ACCESSIBILITY AMONGST ALL CONSUMER CHANNELS.

PRODUCTS

         Currently,  the  Company's  natural  consumer  products  consist of two
dietary supplement lines,  PURECHOICE(TM) and SOLUTIONS(TM).  Although there may
be a fixed number of different  products within each line at any time,  variable
factors  such as counts and sizes of each product make the total number of SKU's
(Shelf Keeping Units)  available within each line subject to change at any time.
In addition,  the Company often  incorporates  product displays for its products
that hold from six (6) to twenty (20) bottles of each product as a marketing aid
to help its retail  customers  display and sell the products to their consumers.
Since the launch of the PURECHOICE(TM) and SOLUTIONS(TM)  lines, the Company has
developed  five (5)  products.  The total number of SKU's  totals  approximately
twenty-six (26).

         SOLUTIONS(TM).  This  line of  products  is  formulated  with  what the
Company considers the most effective  ingredients and dosages to target specific
needs  and  conditions  of  consumers.   SOLUTIONS(TM)  currently  includes  the
following products:

                                      -7-
<PAGE>
                          BAYWOOD INTERNATIONAL, INC.


            PRODUCT NAME                                      TARGETED FUNCTION
            ------------                                      -----------------
 Dr. Harris' Original Snore Formula                           Relief of Snoring
Dr. Harris' Original Allergy Formula                         Relief of Allergies
              N-Cal(TM)                                          Weight Loss

          PURECHOICE(TM).   This  line  is  composed  of  high  quality   single
ingredient  products  that  target  those needs of the  consumer  for a specific
product in the marketplace.  Where the SOLUTIONS(TM)  line may combine a variety
of ingredients to target a specific  condition,  PURECHOICE(TM) may include only
one component for the consumer to choose.  Single  ingredients may include,  but
are not limited  to,  vitamins,  minerals,  herbs,  botanical  extracts or other
organic sulfur and non-sulfur compounds.  PURECHOICE(TM)  currently includes the
following products:

        PRODUCT NAME                                        FUNCTION
        ------------                                        --------
SAMe (S-Adenosyl-Methionine)                       Joint and Emotional Health
    Colostrum IgG30 1000                        Immune System Support and Energy

          The Company  intends to develop  other new  products  and SKU's within
these lines in the future.  Management  believes that there may be products that
are developed outside of these lines that need their own separate  identity.  In
addition,  there may be products that are developed  internally that are part of
different  categories and products that are attained  through  acquisition  that
have already established their brand identity within the marketplace. Management
can provide no assurances as to the continued  viability of any current products
within the marketplace or the expected marketability of any future products that
the Company may develop or acquire.

INTERNATIONAL

         Certain of the Company's  products are sold in Canada.  Sales in Canada
are conducted  through  distributors who service various retail outlets in their
respective territories.

RESULTS OF OPERATIONS

         Net sales for the  three  months  ended  March 31,  2000 were  $359,082
compared to net sales of $37,971  for the same period last year,  an increase of
$321,111 or 845.7%.  This  increase is due to sales of the Company's new product
lines that were launched in July 1999,  PURECHOICE(TM)  and  SOLUTIONS(TM).  The
Company's  objective is to become a recognized  leader in the  provision of high
quality brand name natural  products that are marketed in niche market  segments
in which  its  products  can be among the  market  leaders  in their  respective
categories.  The  Company's  potential  for  growth  at this time  involves  the
continued   development  of  niche  products  within  the   PURECHOICE(TM)   and
SOLUTIONS(TM)  lines and the  establishment  of other  branded lines that can be
marketed and sold into retail  channels.  Retail  channels  include health food,
pharmacy,  grocery and drug chains,  mail order and internet  distribution.  The
Company considers its biggest potential to involve the development and marketing
of a broad base of consumer  products that are based on natural compounds rather
than  a  specific  category  of  natural  products.  Through  consistent  active
involvement  in the trends that affect  consumers,  the Company  will attempt to
focus on  building  brand  identity  for each of the types of  product  lines it
develops  either  internally or attains  through  acquisitions  of other natural
product companies. Additionally, the Company strives to achieve its objective by
identifying brands with favorable demographic appeal, quickly modifying products
and promotions in response to changing consumer demands, and developing creative
and cost-effective marketing and advertising programs.

         The Company's  gross profit margin for the three months ended March 31,
2000 was 64.7% compared to 41.6% for the same period last year. The variation in

                                      -8-
<PAGE>
                          BAYWOOD INTERNATIONAL, INC.


gross profit margin is due to the dramatic change in the Company's product lines
that are currently being sold in 2000 compared to prior periods.  In addition to
this change in product lines, the significant shift in distribution channels has
impacted and will continue to impact the Company's  gross profit  margins in the
future based on such factors as discounts and promotions that are often utilized
as part of the Company's marketing programs.

         Selling, general and administrative expenses for the three months ended
March 31, 2000 were $443,670 compared to $216,353 for the same period last year,
an increase of 105.1%.  Overall corporate  expenditures as a percentage of sales
have  decreased   compared  to  the  same  period  last  year  while   marketing
expenditures have increased including advertising, sales salaries,  commissions,
royalties  and  new  product  development  expenses.  Advertising,   promotions,
royalties and expenses related to new products and program  development were the
largest portion of selling,  general and  administrative  expenses for the three
months ended March 31, 2000 totaling approximately $193,000.

         There is no income tax benefit recorded  because any potential  benefit
of the operating  loss  carryforwards  has been equally offset by an increase in
the valuation allowance on the deferred income tax asset.

         Net loss for the three  months ended March 31, 2000 was  $(236,142)  or
$(.01) per share  compared to a net loss of  $(214,183)  or $(.01) per share for
the same period last year.

         For the three months  ended March 31,  2000,  the "Year 2000 Issue" did
not  present any  operational  problems  for the Company and did not  materially
effect the Company's relationships with customers, vendors and others. The "Year
2000 Issue" arose because many existing  computer programs use only the last two
digits to refer to a year.  Therefore,  these computer  programs do not properly
recognize a year that  begins with "20"  instead of the  familiar  "19".  If not
corrected,  many computer  applications  could fail or create erroneous results.
The Company  also  relies on  standard  office  productivity  software  which is
represented as being Y2K compliant.

         The  Company  implemented  various  modifications  to  ensure  that its
computer  applications  and equipment  functioned  properly in the Year 2000 and
beyond.  (For this  purpose,  the term  "computer  equipment  and  applications"
includes systems  commonly  referred to as information  technology  systems ("IT
Systems"),   such  as  data  processing,   accounting,   telephone,   and  other
miscellaneous systems as well as systems that are not commonly referred to as IT
Systems such as fax machines, etc.

         All internal and external costs associated with the Company's Year 2000
compliance  activities were expensed as incurred.  The Company believes that the
costs of  addressing  the Year 2000 issue did not have a material  impact on the
Company's financial position.

OTHER INFORMATION

         Interest  Expense was $37,508 in three months ended March 31, 2000. The
increase is due to the  Company's  interest  expense  incurred  from interest on
notes payable to officers, directors and other third parties.

         In order to compensate certain officers and key employees, the Board of
Directors has granted options to purchase the Company's  common stock. The Board
of Directors  granted  3,750,000  options in 1999.  The exercise  price of those
options is $0.15 per share and vest according to certain performance  guidelines
as set forth by the Board of Directors.  Further  details of these option grants
are  incorporated  herein by reference to the Company's  1999  Definitive  Proxy
Statement dated June 29, 1999.

                                       -9-
<PAGE>
                          BAYWOOD INTERNATIONAL, INC.

         Under the  terms of note  payable  agreements  with  certain  officers,
directors and third  parties,  the Company has granted  warrants to purchase the
Company's  common stock.  In most cases,  the warrants accrue to the noteholders
after the six month  term of the notes  and are  thereafter  exercisable  by the
noteholders  at prices  ranging  from $0.08 to $0.24 per share.  As of March 31,
2000,  approximately  $958,000  has been  borrowed  from these  noteholders  and
approximately 1,916,000 warrants have so far been accrued under them.

         Interest  income for the three  months ended March 31, 2000 of $207 was
generated  from the Company's  invested cash balance in  interest-bearing  money
market accounts.

         The Company expects its expenditures for marketing costs to increase as
it attempts to diversify  its customer  base and expand in the domestic  market.
The Company will be selective in its  expenditures  for marketing  related items
and  intends  to begin  advertising  and  promoting  more  heavily  in  domestic
programs.

         The market for natural products industry is highly  competitive in each
of  the  Company's  existing  and  anticipated  product  lines  and  methods  of
distribution.  Numerous  manufacturers and distributors compete with the Company
for customers  throughout the United States and  internationally in the packaged
nutritional  supplement  industry  selling  products to  retailers  such as mass
merchandisers, drug store chains, independent pharmacies and health food stores.
Many of the Company's  competitors are substantially larger and more experienced
than the Company,  have longer operating  histories and have materially  greater
financial and other  resources than the Company.  Many of these  competitors are
private companies,  and therefore,  the Company cannot compare its revenues with
respect to the sales volume of each  competitor.  There can be no assurance that
the Company will be able to compete  successfully  with its more established and
better capitalized competitors.

CAPITAL EXPENDITURES

         During the three  months  ended  March 31,  2000 and 1999,  the Company
incurred $35,930 and zero in capital  expenditures for computers,  equipment and
fixtures,  respectfully.  As of March 31,  2000,  the  Company  had no  material
commitments for capital expenditures.

LIQUIDITY AND CAPITAL RESOURCES

         As of the three months  ended March 31, 2000,  the Company had $440,536
in current  assets of which  $284,346 or 64.5% was cash and  receivables.  Total
current  liabilities  including  notes  payable  for  the  same  period  totaled
$1,776,406.  This represents a ratio of current assets to current liabilities of
 .25 at March 31,  2000.  The Company has  extended  payment  terms with  certain
vendors and has borrowed funds from certain officers and directors. The terms of
the debt with the  officers  and  directors  are such that it is  classified  as
current liabilities as of March 31, 2000

         Management  is  currently  exploring  alternatives  for raising debt or
equity  financing in order to properly fund the Company's  working capital needs
and to  significantly  increase the Company's  sales growth of new products into
new distribution  channels.  Certain officers,  directors and third parties have
funded operations throughout 1999 and the first quarter of 2000 through loans to
the Company. In addition,  certain officers have elected to defer the payment of
their salaries to conserve cash.  These deferred  salaries have been accrued and
are properly  reflected in the financial  statements of the Company.  Management
intends to pay these deferred salaries in the future when the Company is able to
maintain a higher cash  balance.  It is expected  that the Company  will require
$750,000 to $1,000,000 in debt or equity  financing  within the next six to nine
months to support its operations. In addition,  another $500,000 may be required
as officer and director notes become due and payable.  Management  believes that
it will be  successful  in raising the funds  required to meet its  obligations.
However,  there can no assurances that the cash can be successfully  raised.  If
the Company  cannot raise the  capital,  the effect may be that the Company will
not meet its projections for growth.

                                      -10-
<PAGE>
                          BAYWOOD INTERNATIONAL, INC.


                 "CAUTION REGARDING FORWARD-LOOKING STATEMENTS"

         CERTAIN  STATEMENTS  CONTAINED  IN THIS  REPORT THAT ARE NOT RELATED TO
HISTORICAL RESULTS,  INCLUDING,  WITHOUT  LIMITATIONS,  STATEMENTS REGARDING THE
COMPANY'S  BUSINESS STRATEGY AND OBJECTIVES AND FUTURE FINANCIAL  POSITION,  ARE
FORWARD-LOOKING  STATEMENTS  WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES
ACT AND SECTION 21E OF THE  EXCHANGE  ACT AND INVOLVE  RISKS AND  UNCERTAINTIES.
ALTHOUGH   THE   COMPANY   BELIEVES   THAT  THE   ASSUMPTIONS   ON  WHICH  THESE
FORWARD-LOOKING  STATEMENTS ARE BASED ARE REASONABLE,  THERE CAN BE NO ASSURANCE
THAT SUCH  ASSUMPTIONS WILL PROVE TO BE ACCURATE AND ACTUAL RESULTS COULD DIFFER
MATERIALLY FROM THOSE DISCUSSED IN THE FORWARD-LOOKING STATEMENTS.  FACTORS THAT
COULD CAUSE OR CONTRIBUTE TO SUCH DIFFERENCES  INCLUDE,  BUT ARE NOT LIMITED TO,
THOSE SET FORTH IN THE FOLLOWING SECTION,  AS WELL AS THOSE DISCUSSED  ELSEWHERE
IN THIS  REPORT.  ALL  FORWARD-LOOKING  STATEMENTS  CONTAINED IN THIS REPORT ARE
QUALIFIED IN THEIR ENTIRETY BY THIS CAUTIONARY STATEMENT.

FACTORS THAT MAY AFFECT FUTURE RESULTS

         The Company believes that results of operations in any quarterly period
may be  impacted  by factors  such as delays in the  shipment of new or existing
products,  difficulty in the manufacturer  acquiring critical product components
of acceptable quality and in required quantity, timing of product introductions,
increased competitions, the effect of announcements and marketing efforts of new
competitive products, a slower growth rate in the Company's target markets, lack
of market acceptance of new products and adverse changes in economic  conditions
in any of the countries in which the company does  business.  Due to the factors
noted above,  the  Company's  future  earnings and stock price may be subject to
significant  volatility.  Any  shortfall  in revenues  or  earnings  from levels
expected by the investing public or securities  analysts could have an immediate
and  significant  adverse  effect on the trading price of the  Company's  common
stock.

                                      -11-
<PAGE>
PART II - OTHER INFORMATION

ITEM 1 - LEGAL PROCEEDINGS

         None

ITEM 2 - CHANGES IN SECURITIES

         None

ITEM 3 - DEFAULTS UPON SENIOR SECURITIES

         None

ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         None

ITEM 5 - OTHER INFORMATION

         None

ITEM 6 - EXHIBITS AND REPORTS ON FORM 8-K

         (a) Exhibits

         Exhibit                                                     Method of
         Number    Exhibit Name                                       Filing
         ------    ------------                                       ------

           3.1     Articles of Incorporation, as amended                 *

           3.2     By-Laws                                              **

           4.1     Specimen Common Stock Certificate                    ***

           4.2     Description of Common Stock                         ****

           4.3     Certificates of Designation for Preferred           *****
                     Shares

           4.4     Certificates of Designation for Class D            ******
                     Redeemable Convertible Preferred Stock

          27.1     Financial Data Schedule                         Exhibit filed
                                                                     herewith

- ----------
*         Incorporated  by  reference  to Exhibit  3.1 of annual  report on Form
          10-KSB (file no. 0-22024) filed on April 18, 1996.

**        Incorporated  by reference to Exhibit 3 of  Registration  Statement on
          Form S-1 (file no.  33-10236)  filed on January 27, 1987, and declared
          effective on February 14, 1988.

***       Incorporated  by reference to Exhibit 1 of  Registration  Statement on
          Form 8-A  (File  no.  022024)  filed  on July 2,  1993,  and  declared
          effective on July 9, 1993.

****      Incorporated by reference to page 31 of Registration Statement on Form
          S-1 (file no.  33-10236)  filed on  January  27,  1987,  and  declared
          effective on February 14, 1988.


*****     Incorporated  by reference to Exhibit 4.3 of quarterly  report on Form
          10-QSB (file no. 0-22024) filed on August 11, 1997.

******    Incorporated  by reference to Exhibit 4.4 of quarterly  report on Form
          10-QSB (file no. 0-22024) filed on May 17, 1999.

          (b) Reports on Form 8-K

              None

                                      -12-
<PAGE>
                                   SIGNATURES

         In accordance with the requirements of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


BAYWOOD INTERNATIONAL, INC.
(Registrant)



By: /s/ Neil Reithinger                                       Date: May 15, 2000
    ------------------------------------
Neil Reithinger
Chairman of the Board, President, C.E.O.
and Principal Accounting Officer

<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 806175
<NAME> BAYWOOD INTERNATIONAL, INC.
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<EXCHANGE-RATE>                                      1
<CASH>                                          71,462
<SECURITIES>                                         0
<RECEIVABLES>                                  231,698
<ALLOWANCES>                                    18,814
<INVENTORY>                                    128,584
<CURRENT-ASSETS>                               440,536
<PP&E>                                          55,479
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 571,015
<CURRENT-LIABILITIES>                          604,518
<BONDS>                                              0
                                0
                                     55,000
<COMMON>                                        26,966
<OTHER-SE>                                 (1,287,357)
<TOTAL-LIABILITY-AND-EQUITY>                   571,015
<SALES>                                        359,082
<TOTAL-REVENUES>                               359,082
<CGS>                                          126,658
<TOTAL-COSTS>                                  443,670
<OTHER-EXPENSES>                              (12,612)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              37,508
<INCOME-PRETAX>                              (236,142)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (236,142)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (236,142)
<EPS-BASIC>                                     (0.01)
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission